Cerevel Therapeutics Holdings, Inc. (673.): Stock quote, stock chart, quotes, analysis, advice, financials and news for Stock Cerevel Therapeutics Holdings, Inc ...Cerevel Therapeutics (CERE) stock price, charts, trades & the US's most popular discussion forums. Free forex prices, toplists, indices and lots more.Leading institutional investors commit $320 million through a common stock private investment in public equity (“PIPE”) led by Bain Capital, Perceptive Advisors, Pfizer Inc. and other top-tier healthcare investors. Upon completion of the business combination, a combined $445 million of expected net proceeds from the PIPE and cash held in Arya II’s …CAMBRIDGE, Mass., Oct. 11, 2023 (GLOBE NEWSWIRE) -- Cerevel Therapeutics Holdings, Inc. (Nasdaq: CERE), a company dedicated to unraveling the mysteries of the brain to treat neuroscience diseases, announced today the pricing of its previously announced underwritten public offering of 19,728,189 shares of its common stock at a …When picking the best stocks under $10 to buy, it's important to identify fundamentally strong and non-speculative stocks. These are fundamentally strong and non-speculative stocks...CERE - Cerevel Therapeutics Holdings, Inc. Stock - Share Price, Short Interest, Short Squeeze, Borrow Rates (NasdaqCM)On Wednesday, the largest trades in Cerevel options were put spreads - a combination of December put options that would offer protection against a slide in the stock price below $35.Dec 7, 2023 · Trading in options on Cerevel had experienced an unusual surge along with its stock price in the days before Wednesday's deal announcement, with upside call options drawing hefty interest.Price/Cash Flow N/A. Price/Book 28.32. Trade CERE with: Price/Earnings ttm 0.00. Earnings Per Share ttm -2.50. Most Recent Earnings $-0.61 on 11/01/23. Latest Earnings …That represents a nearly 22% premium over the stock’s closing price on Wednesday. AbbVie chairman and CEO Richard Gonzalez said the following about the deal to acquire Cerevel Therapeutics.Dec 6, 2023 · Cerevel shares jumped 14% to $42.20 in afterhours trading in New York on Wednesday. Exclusive-AbbVie nears roughly $8 billion deal for drug developer Cerevel-sources Add a CommentPharmaceutical giant AbbVie Inc. sold $15 billion of bonds in the US investment-grade market on Thursday to help fund its acquisitions of ImmunoGen Inc. …Emraclidine. We are developing emraclidine for the treatment of both schizophrenia and Alzheimer’s disease psychosis. Emraclidine was rationally designed as a positive allosteric modulator (PAM) that selectively targets the muscarinic acetylcholine 4 receptor subtype (M4) to harness the potential anti-psychotic benefit believed to be associated with M4 …The price represent a premium of 22% over Cerevel's closing ... Cerevel Therapeutics prices $450M stock; Seeking Alpha’s Quant Rating on Cerevel Therapeutics; Recommended For You.Since its IPO on the Shenzhen stock exchange, its share price has gone up every day by the exact same amount. Baofeng Technologies is China’s best performing stock this year. Since...Aug 10, 2022 · In connection with the common stock offering, Cerevel expects to grant the underwriters of such offering a 30-day option to purchase up to an additional $37.5 million of shares of its common stock at the public offering price, less the underwriting discounts and commissions. Jun 29, 2021 · In connection with this offering, Cerevel expects to grant the underwriters a 30-day option to purchase up to an additional 2,100,000 shares of common stock at the public offering price, less the ...Today's High Today's Low 52 Week High 52 Week Low Stock Chart Data Provided by Refinitiv. Minimum 15 minutes delayed.CAMBRIDGE, Mass., July 01, 2021 (GLOBE NEWSWIRE) -- Cerevel Therapeutics (Nasdaq: CERE), a company dedicated to unraveling the mysteries of the brain to treat neuroscience diseases, announced today the pricing of its previously announced underwritten public offering of 14,000,000 shares of common stock at a public offering …3 days ago · 11 analysts have issued 12 month price targets for Cerevel Therapeutics' stock. Their CERE share price targets range from $22.00 to $45.00. On average, they anticipate the company's stock price to reach $39.64 in the next twelve months. This suggests that the stock has a possible downside of 3.0%. Discover Cerevel Therapeutics Holdings' earnings and revenue growth rates, forecasts, and the latest analyst predictions while comparing them to its industry peers. ... Cerevel Therapeutics prices $300M in notes offering, $254M in stock offering Aug 12. President notifies of intention to sell stock Aug 11.Norbert Riedel, Ph.D., is President and Chief Executive Officer of Aptinyx Inc., a biopharmaceutical company, where he also serves as a member of the board of directors. Dr. Riedel was formerly president and chief executive officer of Naurex Inc., the predecessor company acquired by Allergan and from which Aptinyx and its technology were spun out.Unraveling the mysteries of the brain to treat neuroscience diseases Cerevel Therapeutics is working relentlessly to find paths through complexity in an effort to bring real progress and new treatment options to people living with some of the most devastating neuroscience diseases. Transforming what is possible in neuroscience We are a team of experts …Cerevel Therapeutics Holdings, Inc. Common Stock (CERE) Stock Price, Quote, News & History | Nasdaq. Investors may trade in the Pre-Market (4:00-9:30 a.m. ET) and the …Dec 6, 2023 · AbbVie will acquire all outstanding Cerevel common stock for $45.00 per share in cash. The proposed transaction is subject to customary closing conditions, including receipt of regulatory approvals and approval by Cerevel shareholders. Cerevel Therapeutics is advancing its current research and development programs while exploring new modalities through internal research efforts, external collaborations or potential acquisitions. In depth view into CERE (Cerevel Therapeutics Holdings) stock including the latest price, news, dividend history, earnings information and financials.On average, Wall Street analysts predict. that Cerevel Therapeutics Holdings's share price could reach $44.00 by Dec 28, 2024. The average Cerevel Therapeutics Holdings stock price prediction forecasts a potential upside of 1.69% from the current CERE share price of $43.27 .Unraveling the mysteries of the brain to treat neuroscience diseases Cerevel Therapeutics is working relentlessly to find paths through complexity in an effort to bring real progress and new treatment options to people living with some of the most devastating neuroscience diseases. Transforming what is possible in neuroscience We are a team of experts …October 6, 2020 Cerevel Therapeutics Announces First Patient Dosed in Phase 2 Trial of darigabat, an Investigational Therapy in Development for the Treatment of Epilepsy. September 14, 2020 Cerevel Therapeutics to Present at the Morgan Stanley 18th Annual Global Healthcare Conference. July 30, 2020 Cerevel Therapeutics and Arya Sciences ...Dec 4, 2023 ... CERE has risen $1.66 from the previous closing price of $26.00 on volume of 730,796 shares. Over the past year the S&P 500 has gained 13.72% ...If you want to keep up to date on the stock market you have a device in your pocket that makes that possible. Your phone can track everything finance-related and help keep you up t...CAMBRIDGE, Mass., Aug. 12, 2022 (GLOBE NEWSWIRE) -- Cerevel Therapeutics Holdings, Inc. (“Cerevel”, “we”, “us” or “our”) (Nasdaq: CERE), a company dedicated to unraveling the mysteries of the brain to treat neuroscience diseases, announced today the pricing of its previously announced underwritten public offering of 7,250,000 shares of its …Feb 16, 2024 · A high-level overview of Cerevel Therapeutics Holdings, Inc. (CERE) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. Dec 6, 2023 ... -based neuroscience company for $45 per share in cash, a 22% premium to Cerevel's closing price on Wednesday. However, the company's stock price ...6 days ago · As of Feb 21, 2024 9:00pm Delayed Price Post-Trading: $55.60 0.00. ... Thinking about trading options or stock in Novo Nordisk, Vale, Cerevel Therapeutics, Braze Inc, or Alphabet Inc? PR Newswire ...Cerevel Therapeutics Holdings Inc. historical stock charts and prices, analyst ratings, financials, and today’s real-time CERE stock price.The Investor Relations website contains information about Cerevel Therapeutics's business for stockholders, potential investors, and financial analysts. Aug 3, 2023 · Cerevel Therapeutics (CERE) continued to trade on Thursday as Bank of America downgraded the stock citing delays for some of CERE's key data readouts. Read more here.Managing Director, Bain Capital. Chris Gordon is a Managing Director at Bain Capital. He joined the firm in 1997 and has significant experience in private equity investing, with a specialized focus in the healthcare sector. He currently leads Bain Capital’s North American healthcare team and is a member of the investment committee for the ...Dec 7, 2023 · According to 5 analyst offering 12-month price targets in the last 3 months, Cerevel Therapeutics Hldg has an average price target of $37.2 with a high of $45.00 and a low of $25.00. Below is a ...That represents a nearly 22% premium over the stock’s closing price on Wednesday. AbbVie chairman and CEO Richard Gonzalez said the following about the deal to acquire Cerevel Therapeutics.5 days ago · Which executives are buying and selling shares of Cerevel Therapeutics stock? View the latest CERE insider trading activity at MarketBeat. Skip to main content. S&P 500 4,981.80. DOW 38,612.24. ... How to trade options if you believe a big price move is coming ; Learn. Read investment guides, how-to articles, and explainers ...Interactive Chart for Cerevel Therapeutics Holdings, Inc. (CERE), analyze all the data with a huge range of indicators. It agreed to buy Cerevel Therapeutics (CERE-0.44%) ... That makes AbbVie's current PEG ratio of 1.7 a fair price for the stock. Plus, investors get the added benefit of …Quality stocks at a reasonable price · Multibaggers · Top ROE · Investment Themes ... 12 772 M $. Bio Therapeutic Drugs · Stock · Equities &middo...Cerevel Therapeutics Holdings, Inc. (673.FRA): Stock quote, stock chart, quotes, analysis, advice, financials and news for Stock Cerevel Therapeutics Holdings, Inc. | Deutsche Boerse AG: 673 | Deutsche Boerse AG ... Certain Common Stock of Cerevel Therapeutics Holdings, Inc. are subject to a Lock-Up Agreement Ending on 10-DEC …That represents a nearly 22% premium over the stock’s closing price on Wednesday. AbbVie chairman and CEO Richard Gonzalez said the following about the deal to acquire Cerevel Therapeutics.Cerevel Therapeutics Holdings, Inc. (CERE.NASDAQ) : Stock quote, stock chart, quotes, analysis, advice, financials and news for Stock Cerevel Therapeutics Holdings ... Analyst Price Target Analysis. Centerview reviewed available stock price targets for the Company Shares in thirteen publicly available Wall Street research ...That represents a nearly 22% premium over the stock’s closing price on Wednesday. AbbVie chairman and CEO Richard Gonzalez said the following about the deal to acquire Cerevel Therapeutics.Cerevel Therapeutics Holdings Inc stock price (CERE) NASDAQ: CERE. Buying or selling a stock that’s not traded in your local currency? Don’t let the currency conversion trip …Feb 19, 2024 · Research Cerevel Therapeutics Holdings' (Nasdaq:CERE) stock price, latest news & stock analysis. Find everything from its Valuation, Future Growth, Past Performance and more. What is Cerevel Therapeutics Hldg stock price doing today? As of February 16, 2024, CERE stock price declined to $42.57 with 2,125,419 million shares trading. What is Cerevel Therapeutics Hldg's Beta?In addition, Cerevel granted the underwriters a 30-day option to purchase up to an additional 1,087,500 shares of its common stock at the public offering price, less underwriting discounts and ...3 days ago · 11 analysts have issued 12 month price targets for Cerevel Therapeutics' stock. Their CERE share price targets range from $22.00 to $45.00. On average, they anticipate the company's stock price to reach $39.64 in the next twelve months. This suggests that the stock has a possible downside of 3.0%. Cerevel shares jumped 14% to $42.20 in afterhours trading in New York on Wednesday. (Reporting by David Carnevali in New York; Editing by Greg Roumeliotis) Related QuotesFeb 14, 2024 · The Cerevel Therapeutics Holdings, Inc. stock price gained 0.89% on the last trading day (Wednesday, 14th Feb 2024), rising from $42.89 to $43.27. During the last trading day the stock fluctuated 0.651% from a day low at $43.00 to a day high of $43.28. The price has been going up and down for this period, and there has been a 3.27% gain for the ... CVL-871 We are developing CVL-871 for the treatment of dementia-related apathy. Apathy is among the most common neuropsychiatric co-morbidities associated with dementia, placing great stress on both caregivers and families and correlating very highly with disease progression. About the Mechanism of CVL-871 Dopamine acting on D1/D5 receptor …The initial conversion rate is 21.5633 shares of common stock per $1,000 principal amount of the notes, which represents an initial conversion price of approximately $46.38 per share of common stock. The initial conversion price represents a premium of approximately 32.5% above the initial price to the public of $35.00 per share in Cerevel’s ...Get the latest Cerevel Therapeutics Holdings, Inc. (CERE) stock news and headlines to help you in your trading and investing decisions.Cerevel Therapeutics Holdings, Inc. Common Stock (CERE) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. Dec 7, 2023 ... Is Abbvie Stock a Buy Now!? | Abbvie (ABBV) Stock Analysis ... Amazon CEO Andy Jassy: Whenever customers can trade down in price they do so.Stock Price, News, Quote and Profile of CEREVEL THERAPEUTICS HOLDING(NASDAQ:CERE) stock. General stock ratings, overview and activity description.Are you tired of spending endless hours searching for high-quality stock photos only to discover that they come with a hefty price tag? Look no further. In this article, we will ex...176.59. +2.17. +1.24%. NEW YORK (Reuters) -Trading in the options of Cerevel Therapeutics Holdings Inc experienced an unusual surge along with its stock price in the days before Wednesday's ...Stock analysis for Cerevel Therapeutics Holdings Inc (ARYB:US) including stock price, stock chart, company news, key statistics, fundamentals and company profile.An M4 full agonist for the treatment of mania associated with bipolar 1 disorder. We are pursuing a number of other undisclosed targets, including those with disease-modifying potential. Some of these programs were initiated by Pfizer while others were developed internally at Cerevel Therapeutics through application of human genetic analyses ...AbbVie will acquire all outstanding Cerevel common stock for $45.00 per share in cash. The proposed transaction is subject to customary closing conditions, including receipt of regulatory ...Summary of all time highs, changes and price drops for Cerevel Therapeutics Holdings; Historical stock prices; Current Share Price: US$42.57: 52 …The price represent a premium of 22% over Cerevel's closing ... Cerevel Therapeutics prices $450M stock; Seeking Alpha’s Quant Rating on Cerevel Therapeutics; Recommended For You.AbbVie will acquire all outstanding Cerevel common stock for $45.00 per share in cash. The proposed transaction is subject to customary closing conditions, including receipt of regulatory ...Transaction Terms AbbVie will acquire all outstanding Cerevel common stock for $45.00 per share in cash. The proposed transaction is subject to customary closing conditions, including receipt of regulatory approvals and approval by Cerevel shareholders. ... Mizuho Raises Price Target on Cerevel Therapeutics to $45 From $25 to Reflect Sale …The current price Cerevel Therapeutics Hldg (CERE) is trading at is $42.88, which is within the analyst’s predicted range. Browse analyst ratings and price targets on all stocks. Popular ChannelsCerevel Therapeutics to Present at Upcoming Investor Conferences. Unraveling the mysteries of the brain to treat neuroscience diseases Cerevel Therapeutics is working relentlessly to find paths through complexity in an effort to bring real progress and new treatment options to people living with some of the most devastating neuroscience diseases. Since its IPO on the Shenzhen stock exchange, its share price has gone up every day by the exact same amount. Baofeng Technologies is China’s best performing stock this year. Since...Oct 12, 2023 · Cerevel Therapeutics prices $450M stock. Oct. 12, 2023 5:30 AM ET Cerevel Therapeutics Holdings, Inc. ... The stock price is up 1% during the pre-market. More on Cerevel Therapeutics. Dec 6, 2023 · AbbVie Inc is nearing an approximately $8 billion deal to acquire Cerevel Therapeutics ... graduated high school at 16, and got the Nvidia logo tattooed on his shoulder when the stock price hit $ ...Dec 7, 2023 · According to 5 analyst offering 12-month price targets in the last 3 months, Cerevel Therapeutics Hldg has an average price target of $37.2 with a high of $45.00 and a low of $25.00. Below is a ...Aug 9, 2023 · Cerevel Therapeutics Holdings Insiders Bought Stock Recently. Over the last quarter, Cerevel Therapeutics Holdings insiders have spent a meaningful amount on shares. In total, insiders bought US$2.5m worth of shares in that time, and we didn't record any sales whatsoever. This makes one think the business has some good points.... or selling, read news, get earnings results, and compare Cerevel Therapeutics Holdings, Inc. Warrant against related stocks people have also bought.Dec 6, 2023 · The price represent a premium of 22% over Cerevel's closing price on Wednesday. Before the deal announcement, Cerevel ( CERE ) shares soared 42% this week on no apparent news. The deal is expectec ... 6 days ago · As of Feb 21, 2024 9:00pm Delayed Price Post-Trading: $55.60 0.00. ... Thinking about trading options or stock in Novo Nordisk, Vale, Cerevel Therapeutics, Braze Inc, or Alphabet Inc? PR Newswire ...AbbVie will acquire all outstanding Cerevel common stock for $45.00 per share in cash. The proposed transaction is subject to customary closing conditions, including receipt of regulatory approvals and approval by Cerevel shareholders. ... negative effects of this announcement or the consummation of the proposed acquisition on the market price ...3 days ago · Trailing Returns Financials Valuation Operating Performance Dividends Ownership Executive $41.04 −1.53 (3.59%) View Full Chart As of Feb 20, 2024 1:00pm Delayed Price Post-Trading: $41.05 0.00... Cerevel Therapeutics is advancing its current research and development programs while exploring new modalities through internal research efforts, external collaborations or potential acquisitions. In depth view into CERE (Cerevel Therapeutics Holdings) stock including the latest price, news, dividend history, earnings information and financials. That represents a nearly 22% premium over the stock’s closing price on Wednesday. AbbVie chairman and CEO Richard Gonzalez said the following about the deal to acquire Cerevel Therapeutics.Cerevel Therapeutics Holdings Inc. historical stock charts and prices, analyst ratings, financials, and today’s real-time CERE stock price.
An M4 full agonist for the treatment of mania associated with bipolar 1 disorder. We are pursuing a number of other undisclosed targets, including those with disease-modifying potential. Some of these programs were initiated by Pfizer while others were developed internally at Cerevel Therapeutics through application of human genetic analyses .... Devon larat
NEW YORK (Reuters) -Trading in the options of Cerevel Therapeutics Holdings Inc experienced an unusual surge along with its stock price in the days before Wednesday's announcement that AbbVie would buy the drug developer in a multi-billion dollar deal. AbbVie said after the market close on Wednesday it would buy Cerevel for …View Cerevel Therapeutics Holdings (CERE) stock price, news, historical charts, analyst ratings, financial information and quotes on Futubull.Edit IPO & Stock Price Section. Cerevel Therapeutics is registered under the ticker NASDAQ:CERE . Stock Symbol NASDAQ:CERE ; IPO Date Oct 28, 2020; Stock chart by . Investors. Edit Investors Section. Number of Lead Investors 2. Number of Investors 19. Cerevel Therapeutics is funded by 19 investors.5 days ago ... Analyst. Target Price. 44.78 ; Investor. New Investor. Fil Ltd ; Insiders. Largest Sold. Sold 50.00K shares ; Trading. Volume. High ; Profitability.What is Cerevel Therapeutics Hldg stock price doing today? As of February 16, 2024, CERE stock price declined to $42.57 with 2,125,419 million shares trading. What is Cerevel Therapeutics Hldg's Beta?On eToro, you can buy $CERE or other stocks and pay ZERO commission! Follow Cerevel Therapeutics Holdings Inc share price and get more information. Terms apply.Dec 7, 2023 · Cerevel was listed on the New York stock market in 2020. Bain and Pfizer hold stakes of about 36% and 15%, respectively. Cerevel shares were up 15.5%, while AbbVie shares were flat in extended ... Cerevel Therapeutics to Present at Upcoming Investor Conferences. Unraveling the mysteries of the brain to treat neuroscience diseases Cerevel Therapeutics is working relentlessly to find paths through complexity in an effort to bring real progress and new treatment options to people living with some of the most devastating neuroscience diseases. Previous Close. 40.93 ; Average Volume. 1.75M ; Market Cap. 7.39B ; Shares Outstanding. 181.43M ; EPS (TTM). -2.50.Cerevel shares jumped 14% to $42.20 in afterhours trading in New York on Wednesday. (Reporting by David Carnevali in New York; Editing by Greg Roumeliotis) Related Quotes3 mo. 6 mo. 1 yr. Data Provided by Refinitiv. Minimum 15 minutes delayed. Learn More. The Investor Relations website contains information about Cerevel Therapeutics's business for stockholders, potential investors, and financial analysts.Discover historical prices for CERE stock on Yahoo Finance. View daily, weekly or monthly format back to when Cerevel Therapeutics Holdings, Inc. stock was issued. Stock control is important because it prevents retailers from running out of products, according to the Houston Chronicle. Stock control also helps retailers keep track of goods th...4 days ago · Overview Stock Screener Earnings Calendar Sectors Nasdaq | CERE U.S.: Nasdaq Cerevel Therapeutics Holdings Inc. Watch NEW Set a price target alert After Hours Last Updated: Feb 15, 2024 7:00... Dec 7, 2023 ... AbbVie (ABBV) announced it is acquiring neuroscience drug developer Cerevel Therapeutics (CERE) for $45.00 per share, putting the deal value ....
Popular Topics
Sky cc credit card | Dec 7, 2023 · Cerevel Therapeutics Holdings, Inc. The merger, expected to close in the fourth quarter, will result in a combined company that's expected to be worth around $1.3 billion. Cerevel's management team, including CEO Coles, will continue to lead the new firm, which will trade on the Nasdaq stock exchange under the ticker CERE. At a value of $445 million, the deal is among the …...
Seafood restaurants in cincinnati | Nowadays finding high-quality stock photos for personal or commercial use is very simple. You just need to search the photo using a few descriptive words and let Google do the rest...Cerevel Therapeutics Holdings Inc stock price (CERE) NASDAQ: CERE. Buying or selling a stock that’s not traded in your local currency? Don’t let the currency conversion trip you up. Convert Cerevel Therapeutics Holdings Inc stocks or shares into any currency with our handy tool, and you’ll always know what you’re getting. The North Chicago-based drugmaker is paying $45 a share in cash, a 22% premium to Cerevel’s closing price on Wednesday. The biotech company’s stock had climbed 42% since the end of last week ......
Eclipse from fast and furious | Feb 2, 2024 · View Cerevel Therapeutics (NASDAQ:CERE) historical prices, past price performance, and an advanced CERE stock chart at MarketBeat. Skip to main content S&P 500 4,957.40 (+1.04%)Get the latest Cerevel Therapeutics Holdings Inc. (CERE) stock price, news, buy or sell recommendation, and investing advice from Wall Street professionals.Cerevel Therapeutics Holdings Inc. historical stock charts and prices, analyst ratings, financials, and today’s real-time CERE stock price....
How to find radius of a circle | Research Cerevel Therapeutics Holdings' (DB:673) stock price, latest news & stock analysis. Find everything from its Valuation, Future Growth, Past Performance and more. ... Summary of all time highs, changes and price drops for Cerevel Therapeutics Holdings; Historical stock prices; Current Share Price: US$23.60: 52 Week High: …According to the issued ratings of 11 analysts in the last year, the consensus rating for Cerevel Therapeutics stock is Hold based on the current 9 hold ratings and 2 buy ratings for CERE. The average twelve-month price prediction for Cerevel Therapeutics is $37.82 with a high price target of $45.00 and a low price target of $22.00.October 6, 2020 Cerevel Therapeutics Announces First Patient Dosed in Phase 2 Trial of darigabat, an Investigational Therapy in Development for the Treatment of Epilepsy. September 14, 2020 Cerevel Therapeutics to Present at the Morgan Stanley 18th Annual Global Healthcare Conference. July 30, 2020 Cerevel Therapeutics and Arya Sciences ......
Wwe jey uso | Quality stocks at a reasonable price · Multibaggers · Top ROE · Investment Themes ... 12 772 M $. Bio Therapeutic Drugs · Stock · Equities &middo...Cerevel Therapeutics Holdings, Inc. (CERE) Stock Price, News, Quote & History - Yahoo Finance Canada markets close in 5 hours 7 minutes S&P/TSX 21,278.30 +105.92(+0.50%) S&P 500 5,055.65... Real time Cerevel Therapeutics (CERE) stock price quote, stock graph, news & analysis....
Bunuelos de viento | Track Cerevel Therapeutics Holdings Inc (CERE) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investors Cerevel Therapeutics is advancing its current research and development programs while exploring new modalities through internal research efforts, external collaborations or potential acquisitions. In depth view into CERE (Cerevel Therapeutics Holdings) stock including the latest price, news, dividend history, earnings information and financials.Stocks trading online may seem like a great way to make money, but if you want to walk away with a profit rather than a big loss, you’ll want to take your time and learn the ins an......